What Researchers Did
Researchers conducted a randomized controlled trial across five Nordic hospitals to determine if hyperbaric oxygen therapy could reduce symptoms of late radiation cystitis.
What They Found
The provided abstract describes the study's design and aims to assess if hyperbaric oxygen therapy could mitigate symptoms of late radiation cystitis. However, specific findings, numbers, or percentages from the trial's outcomes were not included in the provided abstract.
What This Means for Canadian Patients
If proven effective, hyperbaric oxygen therapy could offer a valuable treatment option for Canadian patients experiencing late radiation cystitis following pelvic radiotherapy. This could potentially improve quality of life for individuals suffering from this debilitating side effect of cancer treatment.
Canadian Relevance
This study investigates a condition, late radiation cystitis, which falls under Health Canada's recognized indication for hyperbaric oxygen therapy: 'Delayed Radiation Injury (Soft Tissue and Bone Necrosis)'.
Study Limitations
A key limitation of this study is that no masking was applied, which could introduce bias.